What is Radient Technologies?
Radient Technologies operates as a specialized commercial manufacturer, focusing on the development of high-quality cannabinoid-based formulations and proprietary ingredients. Headquartered in Edmonton, Alberta, the company distinguishes itself through advanced extraction and processing technologies that cater to both the pharmaceutical and consumer packaged goods markets. By maintaining a rigorous focus on product purity and formulation consistency, Radient Technologies has established itself as a key player in the North American cannabinoid supply chain. The firm's operational model is centered on bridging the gap between raw botanical inputs and sophisticated, market-ready ingredients, positioning it as a vital partner for brands seeking reliable, high-grade cannabinoid solutions.
How much funding has Radient Technologies raised?
Radient Technologies has raised a total of $13.9M across 3 funding rounds:
Debt
$8.5M
Stock Offering
$5M
Share Placement
$360K
Debt (2019): $8.5M with participation from Moskowitz Capital
Stock Issuance/Offering (2020): $5M led by Undisclosed
Share Placement (2022): $360K, investors not publicly disclosed
Key Investors in Radient Technologies
Moskowitz Capital
A specialized investment firm focusing on providing debt financing and credit solutions to growth-stage companies.
Undisclosed Investors
Undisclosed Investors
What's next for Radient Technologies?
Looking ahead, the strategic deployment of the $360K capital will likely prioritize the enhancement of manufacturing infrastructure and the acceleration of R&D initiatives. As the regulatory environment for cannabinoid products continues to evolve, Radient Technologies is well-positioned to capitalize on emerging market opportunities by scaling its proprietary extraction processes. The company's focus will likely shift toward deepening its commercial partnerships and expanding its product portfolio to meet the increasing demand for standardized, high-potency ingredients. By maintaining a disciplined approach to capital allocation, Radient Technologies aims to sustain its growth trajectory and reinforce its competitive advantage in the global cannabinoid market, ensuring long-term value creation for its stakeholders.
See full Radient Technologies company page
